首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Journal of Bone Oncology
ISSN：2212-1374

Journal of Bone Oncology

J BONE ONCOL
学科领域：医学
是否预警：不在预警名单内
是否OA：是
录用周期：20 Weeks
新锐分区：医学3区
年发文量：66
影响因子：3.5
JCR分区：Q2

基本信息

《骨肿瘤学杂志》（Journal of Bone Oncology）是一本国际同行评审期刊，旨在介绍骨和癌症相关的基础、转化和临床高质量研究。作为第一本致力于癌症诱发骨疾病的期刊，JBO欢迎原创研究文章、综述文章、社论和意见文章。该杂志涵盖的领域包括：骨转移（病理生理学、流行病学、诊断学、临床特征、预防、治疗）转移的临床前模型癌症中的骨微环境（干细胞、骨细胞和癌症相互作用）骨靶向治疗（药理学、治疗靶点、药物开发、临床试验、副作用、结局研究、卫生经济学）癌症治疗引起的骨丢失（流行病学、病理生理学、预防和管理）骨成像（临床和动物、骨骼介入放射学）骨生物标志物（临床和转化应用）放射疗法和放射性同位素骨骼并发症骨痛（机制和管理）骨科癌症手术原发性骨肿瘤临床指南多学科护理关键词：双膦酸盐、骨、乳腺癌、癌症、CTIBL、狄诺塞单抗、转移、骨髓瘤、成骨细胞、破骨细胞、骨肿瘤学、骨肿瘤学、前列腺癌、骨骼、肿瘤。
2212-1374SCIE/Scopus收录/DOAJ开放期刊
3.5
点击查看最新影响趋势>
3.4
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：ONCOLOGY
SCIE
Q2
106/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：ONCOLOGY
SCIE
Q2
140/328
暂无h-index数据
66
点击查看年发文量趋势图>
--20 WeeksUSD2320Medicine-Oncology
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
87.88%100%-
CiteScore：6.10
SJR：1.041
SNIP：1.204
学科类别分区排名百分位
大类：Medicine
小类：Oncology
Q2
116 / 415

期刊高被引文献

Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100230
Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100228
The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche in vivo
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100244
A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.100212
MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100241
Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100218
Atypical femoral fractures from bisphosphonate in cancer patients – Review
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100259
Surgical options and reconstruction strategies for primary bone tumors of distal tibia: A systematic review of complications and functional outcome
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.100209
Prediction of survival after surgical management of femoral metastatic bone disease – A comparison of prognostic models
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100225
Managements of giant cell tumor within the distal radius: A retrospective study of 58 cases from a single center
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.100211
Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100231
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials
来源期刊：Journal of Bone OncologyDOI：10.1016/J.JBO.2019.100252
A nomogram to predict prognosis in Ewing sarcoma of bone
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100223
Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.100215
Aneurysmal bone cyst: A review of 65 patients
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100255
Incidence of fractures in young women with breast cancer - a retrospective cohort study
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100254
A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100268
Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas – A nationwide population-based study
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.11.002
Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100222
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100243
The need for bone biopsies in the diagnosis of new bone lesions in patients with a known primary malignancy: A comparative review of 117 biopsy cases
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.100213
Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100257
Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100233
Novel 3D-printed prosthetic composite for reconstruction of massive bone defects in lower extremities after malignant tumor resection☆
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100220
Tumor derived EDIL3 modulates the expansion and osteoclastogenesis of myeloid derived suppressor cells in murine breast cancer model
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100238
Clear cell chondrosarcoma is an underestimated tumor: Report of 7 cases and meta-analysis of the literature
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100267
Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100232
Bone transport using the Ilizarov method for osteosarcoma patients with tumor resection and neoadjuvant chemotherapy
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100224
Changing landscape of optical imaging in skeletal metastases
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100249
Surgical outcomes of extracorporeal irradiation and re-implantation in extremities for high grade osteosarcoma: A retrospective cohort study and a systematic review of the literature
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.100210
Association of vitamin D receptor gene polymorphisms with osteosarcoma risk and prognosis
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.100208
Have the difficulties and complications of surgical treatment for chondroblastoma of the adjoining knee joint been overestimated?
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100240
Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.100216
Survival and prognosis in malignant giant cell tumor of bone: A population-based analysis from 1984 to 2013
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100260
Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100226
Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100265
Chondroblastoma in pelvis and extremities- a signle centre study of 177 cases
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100248
An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100261
Feasibility of total en-bloc spondylectomy on L5 by a posterior-only approach: An autopsy study
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.10.003
Analgesia from percutaneous thermal ablation plus cementoplasty for cancer bone metastases
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100266
Specific inhibition of PI3Kδ/γ enhances the efficacy of anti-PD1 against osteosarcoma cancer
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.11.001
Application of nomograms to predict overall and cancer-specific survival in patients with chordoma
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100247
Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100236
Evaluating the scope of intramedullary invasion of malignant bone tumor by DCE-MRI quantitative parameters in an animal study
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100269
Histological, epidemiological and anatomical analysis of 193 bone tumours of the scapula
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100258
Intra-articular osteoid osteoma accompanied by extensive bone marrow edema. A clinical and micro-morphological analysis
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100256
Use of endoprostheses for proximal femur metastases results in a rapid rehabilitation and low risk of implant failure. A prospective population-based study
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100264
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100227
The association between adherence with oral bisphosphonates and the risk of breast cancer in post-menopausal women
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2018.10.001
Pelvic reconstruction following resection of tumour involving the whole ilium and acetabulum
来源期刊：Journal of Bone OncologyDOI：10.1016/j.jbo.2019.100234

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
3区
否
否